Cubist Pharmaceuticals has named Jennifer Jackson, Ph.D., senior vice president of regulatory affairs. Jackson will oversee all facets of Cubist’s regulatory affairs, providing oversight for all U.S. and international regulatory matters, including filings and interactions with regulatory authorities. Jackson will report to Steve Gilman, Ph.D., Cubist’s executive vice president of research and development and chief scientific officer.
Jackson joins Cubist from Biogen Idec Hemophilia where she was vice president of regulatory affairs and clinical compliance. Prior to Biogen Idec Hemophilia, Jackson was vice president of regulatory affairs at Vertex Pharmaceuticals.